Back
Cimpress Plc 10K Form
Buy
60
CMPR
Cimpress Plc
Last Price:
$72.00
Seasonality Move:
7.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-26 | 10Q | CMPR/Cimpress Plc Quarterly |
| 2023-04-27 | 10Q | CMPR/Cimpress Plc Quarterly |
| 2023-01-26 | 10Q | CMPR/Cimpress Plc Quarterly |
| 2022-10-27 | 10Q | CMPR/Cimpress Plc Quarterly |
| 2022-04-28 | 10Q | CMPR/Cimpress Plc Quarterly |
| 2022-01-27 | 10Q | CMPR/Cimpress Plc Quarterly |
Receive CMPR News And Ratings
See the #1 stock for the next 7 days that we like better than CMPR
CMPR Financial Statistics
Sales & Book Value
| Annual Sales: | $3.4B |
|---|---|
| Cash Flow: | $-18.6M |
| Price / Cash Flow: | 11.59 |
| Annual Sales: | $-23.16 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 1.30580 |
|---|---|
| Net Income (TTM): | $31.8M |
| Gross Margin: | $1.6B |
| Return on Equity: | 0% |
| Return on Assets: | 1.65% |
Cimpress Plc Earnings Forecast
Key Cimpress Plc Financial Ratios
-
The Gross Profit Margin over the past 25 years for CMPR is 46.97%.
-
The Selling, General & Administrative Expenses for CMPR have been equal to 30.34% of Gross Profit Margin.
-
The Research & Development expenses have been 9.82% of Revenue.
-
The Interest Expense is 896.60% of Operating Income.
-
The Net Earning history of CMPR is 0.38% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 15 years.
Cimpress Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Commercial Services & Supplies |
| Sector: | Industrials |
| Current Symbol: | CMPR |
| CUSIP: | N20146 |
| Website: | cimpress.com |
Debt
| Debt-to-Equity Ratio: | -2.99 |
|---|---|
| Current Ratio: | 0.65 |
| Quick Ratio: | 0.38 |
Price-to-Earnings
| Trailing P/E Ratio: | 126.35 |
|---|---|
| Forward P/E Ratio: | 0 |
CMPR Technical Analysis vs Fundamental Analysis
Buy
60
Cimpress Plc (CMPR)
is a Buy
Is Cimpress Plc a Buy or a Sell?
-
Cimpress Plc stock is rated a BuyThe current Cimpress Plc [CMPR] share price is $73.69. The Score for CMPR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.